SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-054895
Filing Date
2021-04-26
Accepted
2021-04-26 16:05:29
Documents
6
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 tm212508-2_def14a.htm DEF 14A 1181352
2 GRAPHIC lg_osmoticapharma-4c.jpg GRAPHIC 56657
3 GRAPHIC sg_brianmarkison-bw.jpg GRAPHIC 11535
4 GRAPHIC sg_christopherklein-bw.jpg GRAPHIC 9587
5 GRAPHIC tm212508d2_proxy-page1.jpg GRAPHIC 944954
6 GRAPHIC tm212508d2_proxy-page2.jpg GRAPHIC 990238
  Complete submission text file 0001104659-21-054895.txt   3951485
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-38709 | Film No.: 21853818
SIC: 2834 Pharmaceutical Preparations